Multiple Myeloma Clinical Trials in Chicago

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
G
Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin frozen liquid
  • Belantamab mafodotin lyophilized powder
  • New Haven, Connecticut
  • +58 more
2022-03-21
Mar 21, 2022
P
Active, not recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +45 more
2022-03-29
Mar 29, 2022
J
Active, not recruiting
  • Multiple Myeloma
  • Daratumumab IV
  • +3 more
  • Birmingham, Alabama
  • +211 more
2022-03-24
Mar 24, 2022
N
Recruiting
  • Multiple Myeloma
  • +2 more
  • Goodyear, Arizona
  • +16 more
2022-03-18
Mar 18, 2022
E
Recruiting
  • Multiple Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Atlanta, Georgia
  • +1 more
2022-02-25
Feb 25, 2022
P
Recruiting
  • Multiple Myeloma
  • Elranatamab + Nirogacestat
  • Elranatamab + lenalidomide + dexamethasone
  • Coral Gables, Florida
  • +10 more
2022-03-09
Mar 9, 2022
O
Completed
  • Multiple Myeloma
  • Whittier, California
  • +19 more
2022-02-02
Feb 2, 2022
P
Active, not recruiting
  • Multiple Myeloma
  • Elranatamab (PF-06863135)
  • Beverly Hills, California
  • +76 more
2022-01-28
Jan 28, 2022
N
Recruiting
  • Multiple Myeloma
  • PHE885
  • Chicago, Illinois
  • +3 more
2022-01-28
Jan 28, 2022
U
Recruiting
  • Multiple Myeloma
  • Discontinue maintenance therapy SOC
  • Chicago, Illinois
    University of Illinois Cancer Center
2022-01-25
Jan 25, 2022
J
Not yet recruiting
  • Multiple Myeloma
  • Phoenix, Arizona
  • +15 more
2022-01-10
Jan 10, 2022